secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arbutus Biopharma Corp (ABUS)
CIK:        0001447028
Form:       8-K
Filed at:   2023-01-27T23:59:59+00:00
Accession:  0001171843-23-000518
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arbutus Biopharma director Tram Tran resigns effective Feb 26, 2023 for public service role
--------------------------------------------------------------------------------

- Dr. Tram Tran resigned from the Board effective Feb 26, 2023, to begin a public service role on Feb 27.
- She joined the Board in Nov 2021 and served on the Executive Compensation and Human Resources Committee.
- Resignation is not due to any disagreement with the company; board will immediately search for a replacement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1447028/000117184323000518/0001171843-23-000518-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1447028/000117184323000518/f8k_012623.htm
  HTML page:      https://secwatch.observer/filing/0001171843-23-000518

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer